Skip to main content

Month: August 2024

Xtreme One Entertainment Announces Second Quarter 2024 Financial Results Marked by Continued Progress in Live Event Execution and Growth in XFC Brand

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Quarter Highlighted by XFC 50 and XFC Grand Prix Events, Naming of Sports and Entertainment Industry Executive as President DETROIT, Aug. 14, 2024 (GLOBE NEWSWIRE) — Xtreme One Entertainment, Inc. (OTCPink:XONI) (the “Company” or “Xtreme One”) today announced its financial results for the second quarter ending June 30, 2024, details of which have been filed within the Company’s quarterly disclosure statement accessible at https://www.otcmarkets.com/stock/XONI/disclosure. “I’m incredibly proud of the efforts our team demonstrated, as their dedication culminated in the successful production of two live XFC Main events during the quarter, XFC 50 and XFC: Grand Prix II,” commented Chris Defendis, Xtreme One President. “As we continue to evolve in the space, it is clear that our strategy is working; XFC Grand Prix II saw a 52% increase...

Continue reading

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

MIRAMAR, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2024.  Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “We reached a critical milestone recently that has profound implications for the future of our Company — we successfully reached a settlement agreement for an arbitration that created an overhang that hampered our progress for nearly two years. We wasted no time in launching our multi-faceted financing plan, including a significant equity offering...

Continue reading

Agrify Corporation Announces Results for Second Quarter 2024 and Amended Results for First Quarter 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

TROY, Mich., Aug. 14, 2024 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results SummaryRevenue was $3.0 million for the second quarter of 2024, compared to $2.6 million for the first quarter of 2024 and $5.1 million for the second quarter of 2023. Gross profit was $1.7 million for the second quarter of 2024, compared to $0.7 million for the first quarter of 2024 and $0.6 million for the second quarter of 2023.  Operating loss was $1.5 million for the second quarter of 2024, compared to $5.3 million in the second quarter of 2023. Net loss for the second quarter of 2024 was $2.8 million, compared...

Continue reading

Enservco Corporation Reports Results for Second Quarter 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Recently Announced Transactions Expected to Benefit Operating and Financial Performance in Second Half 2024 and Beyond LONGMONT, Colo., Aug. 14, 2024 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV) (“Enservco”, or the “Company”), a diversified provider of energy logistics solutions and specialized well-site services to the domestic energy industry, today announced operational and financial results for the second quarter of 2024. The Company announced on August 9, 2024 the sale of certain Colorado based frac water heating assets of Heat Waves Hot Oil Service, LLC, a wholly owned subsidiary of Enservco, and its exit from the frac water heating business in Colorado. The financial results for Colorado frac water heating services are reported in the Company’s “Completion and Other Services” segment in Enservco’s financial...

Continue reading

Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Written by Customer Service on . Posted in Public Companies.

Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study MT-601 was well tolerated with no observation of cytokine release syndrome (CRS) or immune effector cell associated neurotoxicity syndrome (ICANS) Marker Therapeutics to receive $2 million funding from NIH Small Business Innovation Research (SBIR) program to support clinical investigation of MT-601 in patients with lymphoma HOUSTON, Aug. 14, 2024 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors, today reported corporate updates and financial results for the second quarter ended June 30, 2024. “The second...

Continue reading

Safe & Green Holdings Reports Second Quarter 2024 Results and Provides a Business Update

Written by Customer Service on . Posted in Public Companies.

Gross profit increases over four-fold; operating expenses reduced 48% Reports record sales pipeline in excess of $25 million On track to achieve positive cash flow before year-end MIAMI, Aug. 14, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, reported results for the three months ended June 30, 2024. Key Highlights:Record sales pipeline in excess of $25 million and positive outlook for H2 2024 Gross profit margin in Q2 2024 increased to 12.7% compared to 0.7% for Q2 2023 Operating expenses declined by $2.7 million in Q2 2024 versus the same period last year Company reaffirms guidance it is on track to achieve positive cash flow before year-end Received a term sheet from a premier lender...

Continue reading

XWELL, Inc. Reports Second Quarter 2024 Results

Written by Customer Service on . Posted in Public Companies.

NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2024. Recent Highlights:XWELL delivered 2024 second quarter revenue growth of approximately 14% from the comparable quarter in 2023 driven by stronger demand for services and retail products. In June, XpresSpa opened a new spa in Philadelphia International Airport — its first in a U.S. airport in more than 5 years and the first to leverage the Company’s “labor-lite, tech-forward” offering. In June, the CDC issued a new three-year biosurveillance program RFP which XpresTest is answering and, if awarded, will commence during the third quarter of 2024. It is anticipated that the value of...

Continue reading

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Written by Customer Service on . Posted in Public Companies.

Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) — Biofrontera Inc. (NASDAQ:BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three and six months ended June 30, 2024 and provided a business update. Highlights from the second quarter of 2024 and subsequent weeks included the following:Total revenues for the second quarter of 2024 were $7.8 million, a 34% increase from the same period of the prior year Cash and cash equivalents were $4.4 million as of June 30, 2024, compared with $1.3 million on December 31, 2023 Biofrontera announced the launch of a new, FDA-approved red-light source, the RhodoLED® XL lamp in June and installed several lamps by June 30th, 2024 Took control of all clinical trials relating to Ameluz®...

Continue reading

BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2’24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET

Written by Customer Service on . Posted in Public Companies.

HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its second quarter ended June 30, 2024 (Q2’24). Note, BIO-key’s results for 2023 were restated at year-end and filed with the Company’s 2023 Form 10-K, and as a result Q2’23 and six months ended June 30, 2023 comparisons in this release have been restated. BIO-key will host an investor call Thursday, August 15th at 10:00am ET (details below). Financial HighlightsQ2’24 revenues decreased to $1.1M from $1.9M in Q2’23, principally due to a delay in recognition of approximately $450,000 in software license fees generated by the...

Continue reading

FSI ANNOUNCES SECOND QUARTER, 2024 FINANCIAL RESULTS

Written by Customer Service on . Posted in Public Companies.

A CONFERENCE CALL IS SCHEDULED FOR THURSDAY, AUGUST 15, 2024, 11:00AM EASTERN TIME SEE DIAL IN NUMBER BELOW VICTORIA, BRITISH COLUMBIA, Aug. 14, 2024 (GLOBE NEWSWIRE) — FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE Amex: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. Today the Company announces financial results for second quarter ended June 30, 2024. Mr. Daniel B. O’Brien, CEO, states, “The second quarter results are a solid improvement over the year earlier period. We will try to build on these results over the remainder of the year.” Mr. O’Brien continues, “We also hope that the hard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.